A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.

Miglietta, Federica; Ragazzi, Moira; Fernandes, Bethania; Griguolo, Gaia; Massa, Davide; Girardi, Fabio; Bottosso, Michele; Bisagni, Alessandra; Zarrilli, Giovanni; Porra, Francesca; +11 more... Iannaccone, Daniela; Dore, Leocadia; Gaudio, Mariangela; Santandrea, Giacomo; Fassan, Matteo; Lo Mele, Marcello; De Sanctis, Rita; Zambelli, Alberto; Bisagni, Giancarlo; Guarneri, Valentina; Dieci, Maria Vittoria; (2023) A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer. Clinical cancer research, 29 (17). pp. 3429-3437. ISSN 1078-0432 DOI: https://doi.org/10.1158/1078-0432.CCR-23-0480

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1158/1078-0432.CCR-23-0480

Abstract

Share

Download

Filename: Miglietta-etal-2023-A-prognostic-model-based-on.pdf

Description: This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar